Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
Clinical trial NCT03364530 · RECRUITING
Trial details
- NCT number
- NCT03364530
- Sponsor
- University Hospital, Montpellier
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-11
- Primary completion
- 2025-10-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.